Literature DB >> 12691466

Hepatitis C in the HIV-infected patient.

Mark S Sulkowski1, David L Thomas.   

Abstract

Hepatitis C virus infection is common in people with HIV and represents an increasingly important public health problem. Thus, although there remains a considerable amount of uncertainty about whom to treat and the best way to treat, providers must use available information generated chiefly from patients without HIV to manage HCV infection in coinfected patients. Future efforts should include prospective studies that demonstrate the natural history and optimal management of HIV/HCV-coinfected patients, including the feasibility of liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691466     DOI: 10.1016/s1089-3261(02)00074-0

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  14 in total

1.  Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.

Authors:  Giorgio Perboni; Paolo Costa; Giovanni Carlo Fibbia; Barbara Morandini; Alfredo Scalzini; Alberto Tagliani; Rita Cengarle; Enrico Aitini
Journal:  Oncologist       Date:  2010-02-08

2.  Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.

Authors:  N Ciccarelli; M Fabbiani; P Grima; K Falasca; M Tana; E Baldonero; M Colafigli; M C Silveri; J Vecchiet; R Cauda; S Di Giambenedetto
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

3.  Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patients.

Authors:  Paula Braitstein; Benita Yip; Valentina Montessori; David Moore; Julio S G Montaner; Robert S Hogg
Journal:  CMAJ       Date:  2005-07-19       Impact factor: 8.262

4.  Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.

Authors:  Adam C Yopp; Madhu Subramanian; Mamta K Jain; John C Mansour; Roderich E Schwarz; Glen C Balch; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

5.  HCV co-infection in HIV positive population in British Columbia, Canada.

Authors:  Jane A Buxton; Amanda Yu; Paul H Kim; John J Spinelli; Margot Kuo; Maria Alvarez; Mark Gilbert; Mel Krajden
Journal:  BMC Public Health       Date:  2010-04-29       Impact factor: 3.295

6.  Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals.

Authors:  Pierre Côté; Jean-Guy Baril; Marie-Nicole Hébert; Marina Klein; Richard Lalonde; Marc Poliquin; Danielle Rouleau; Rachel Therrien; Sylvie Vézina; Bernard Willems; Harold Dion; Patrice Junod; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Cécile Tremblay; Benoît Trottier; Sylvie Trottier; Chris Tsoukas; Alain Piché
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-09       Impact factor: 2.471

7.  Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.

Authors:  Daniel Fuster; Judith I Tsui; Debbie M Cheng; Emily K Quinn; Kaku A Armah; David Nunes; Matthew S Freiberg; Jeffrey H Samet
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-17       Impact factor: 2.205

8.  Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection.

Authors:  Brianna L Norton; Lawrence Park; Leah J McGrath; Rae Jean Proeschold Bell; Andrew J Muir; Susanna Naggie
Journal:  AIDS Patient Care STDS       Date:  2012-08-03       Impact factor: 5.078

9.  Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.

Authors:  Jin Zhao; Lina Yi; Jing Lu; Zheng-Rong Yang; Ying Chen; Chenli Zheng; Dan Huang; Yu-Feng Li; Lin Chen; Jinquan Cheng; Hsiang-Fu Kung; Ming-Liang He
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 10.  MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.

Authors:  Archana Gupta; Gokul Swaminathan; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  Viruses       Date:  2012-10-26       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.